共 11 条
[1]
Brammer K.W., Tarbit M.H., A review of the pharmacokinetics of fluconazole (UK-49,858) in laboratory animals and man, Recent trends in the discovery development of antifungal agents, pp. 141-149, (1987)
[2]
Dupont B., Drouhet E., Fluconazole in the management of oropharyngeal candidiasis in predominantly HIV antibody-positive group of patients, Recent trends in the discovery development of antifungal agents, pp. 163-168, (1987)
[3]
Jefcoate C.R., Measurement of substrate and inhibitor binding to microsomal cytochrome P450 by optical difference spectroscopy, Methods in Enzymology, 52, pp. 258-279, (1978)
[4]
Gale E.F., Nature and development of phenotypic resistance to amphotericin B in Candida albicans, Advances in Microbial Physiology, 27, pp. 277-320, (1986)
[5]
Marriott, Richardson K., The discovery and mode of action of fluconazole, Recent trends in the discovery development of antifungal agents, pp. 81-92, (1987)
[6]
Odds F.C., Abbot A.R., Pye G., Troke P.F., Improved method for estimation of azole antifungal inhibitory concentrations against Candida species based on azole/antibiotic interactions, Journal of Medical and Veterinary Mycology, 24, pp. 305-311, (1986)
[7]
Phillips E., Nash P., Culture media, Manual of clinical microbiology, (1985)
[8]
Shaw J.T.B., Tarbit M.H., Troke P.F., Cytochrome P450-mediated sterol synthesis and metabolism: differences in sensitivity to fluconazole and other azoles, Recent trends in the discovery development of antifungal agents, pp. 125-139, (1987)
[9]
Simonetti N., D'Auria F.D., Strippoli V., Increased in vitro sensitivity of C. albicans to fluconazole, Chemotherapy, 37, pp. 32-37, (1990)
[10]
Troke P.F., Efficacy of fluconazole in animal models of superficial and opportunistic systemic fungal infection, Recent trends in the discovery development of antifungal agents, pp. 103-112, (1987)